Skip to main content
Equasens logo

Equasens — Investor Relations & Filings

Ticker · EQS ISIN · FR0012882389 LEI · 96950066I7XVFGZI8L92 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2026-04-30 Registration Form
Country FR France
Listing PA EQS

About Equasens

https://equasens.com

Equasens is a company specializing in healthcare IT solutions for professionals and establishments. It develops and provides a range of products including professional software, electronic equipment, connected devices, and digital health solutions. The company's offerings cater to a diverse client base, including pharmacies, hospitals, nursing homes (EHPADs), home care services, and independent medical practitioners. The primary objective of its solutions is to improve the quality of patient care by facilitating the secure sharing of health data, enhancing communication between different care providers, and optimizing the coordination of care pathways across outpatient, hospital, and home care settings.

Recent filings

Filing Released Lang Actions
Mise à disposition du Document d’Enregistrement Universel 2025
Registration Form
2026-04-30 French
Solid Q1 2026 performance: revenue of €61.4 million (+7.7% reported)
Earnings Release Classification · 1% confidence The document is a press release dated 29 April 2026 providing key highlights of Equasens Group’s Q1 2026 financial performance, including revenue figures, segment breakdowns, outlook, and financial calendar. It is not the full interim report nor just an announcement of a report’s publication; rather, it summarizes quarterly results. This matches the definition of an Earnings Release (ER). Q1 2026
2026-04-29 English
Bonne performance commerciale au T1 2026 : chiffre d’affaires trimestriel de 61,4 M€ (+7,7% en publié)
Earnings Release Classification · 1% confidence The document is a press release dated April 29, 2026, presenting the Group’s Q1 2026 revenue and key commercial highlights, with summary tables of quarterly sales by segment and division, CEO commentary, and forward dates for upcoming releases. It does not include full financial statements or regulatory formats; rather, it is an initial announcement of quarterly financial results. This matches the definition of an Earnings Release (ER). Q1 2026
2026-04-29 French
EQUASENS : ANNULE ET REMPLACE - MISE EN ŒUVRE D’UN NOUVEAU CONTRAT DE LIQUIDITE AVEC NATIXIS ODDO BHF
Regulatory Filings Classification · 1% confidence The document is a press release announcing the implementation of a new liquidity contract with a market maker, detailing the end of the previous contract, amounts held, duration and regulatory references (AMF Decision). This is not a financial report, earnings release, or share buyback programme, but rather a specific regulatory announcement required by the market authority. It fits the fallback “Regulatory Filings” category (RNS) for miscellaneous regulatory notices that do not fall under more specialized classes.
2026-04-01 French
MISE EN ŒUVRE D’UN NOUVEAU CONTRAT DE LIQUIDITE AVEC NATIXIS ODDO BHF
Regulatory Filings Classification · 0% confidence The document is a press release announcing the termination of an existing AMF-regulated liquidity contract and the implementation of a new liquidity contract with Natixis ODDO BHF. It does not present financial results, dividend details, management changes, M&A, share issuance, share repurchases, or detailed interim or annual reporting. It is an official regulatory announcement concerning market‐making arrangements under AMF Decision 2021-01. It does not neatly fit into any specific category such as share issue (SHA) or transaction in own shares (POS), so the appropriate classification is the general fallback category for miscellaneous regulatory announcements: Regulatory Filings (RNS).
2026-03-31 French
Résultats annuels 2025 : Equasens publie de solides performances pour l’ensemble de ses indicateurs financiers
Earnings Release Classification · 1% confidence The document is a press release dated March 30, 2026, titled “Résultats annuels 2025” and provides a summary of Equasens’s full‐year 2025 financial results: revenue, EBITDA, ARR, net income, dividend proposal, divisional breakdowns, cash flows, and management commentary. It is not the full annual report, auditor’s report, or regulatory filing, but rather the company’s initial announcement of its annual results. This fits the definition of an Earnings Release (ER). FY 2025
2026-03-30 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.